Par 7.5 Mg Buspirone Aims To Capture Portion of 15 Mg Split-Tablet Market

Par Pharmaceutical hopes to capture a portion of the 15 mg buspirone market with the March 28 approval of its 7.5 mg strength of the anxiety drug buspirone, a generic equivalent of Bristol-Myers Squibb's BuSpar. Par has 180-day exclusivity for 7.5 mg buspirone.